Company / Operating Income per Share
Veracyte, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.74
FY2025
5-year range
-$1.41 / $0.74
FY2021-FY2025
Trend
+237.2%
vs FY2024
Sector context
#86 of 154
Health Care
What the data says
Operating Income per Share changed +237% YoY in FY2025, a notable deviation from the 9-year average annual change of +17%.
Based on SEC 10-K filings.
0.74 in FY2025.
Improved from $-1.19 to $0.74 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#86 of 154 in Health CareTop 56% of 154This company $0.74 Sector average $4.29
▼
-82.7% below sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 237.2% year-over-year.
- Ranks #86 out of 154 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.74 | +237.2% |
| FY2024 | $0.22 | +118.5% |
| FY2023 | -$1.19 | -106.4% |
| FY2022 | -$0.58 | +59.0% |
| FY2021 | -$1.41 | -214.1% |
| FY2020 | -$0.45 | -21.0% |
| FY2019 | -$0.37 | +43.8% |
| FY2018 | -$0.66 | +33.6% |
| FY2017 | -$0.99 | +5.4% |
| FY2016 | -$1.05 | +29.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026